gsk-1070916 and Urinary-Bladder-Neoplasms

gsk-1070916 has been researched along with Urinary-Bladder-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for gsk-1070916 and Urinary-Bladder-Neoplasms

Article	Year
Genome-wide screening for the G-protein-coupled receptor (GPCR) pathway-related therapeutic gene Bioengineered, 2021, Volume: 12, Issue:1 Bladder cancer is one of the most severe genitourinary cancers, causing high morbidity worldwide. However, the underlying molecular mechanism is not clear, and it is urgent to find target genes for treatment. G-protein-coupled receptors are currently a target of high interest for drug design. Thus, we aimed to identify a target gene-related to G-protein-coupled receptors for therapy. We used The Cancer Genome Atlas (TCGA) and DepMap databases to obtain the expression and clinical data of Topics: Aza Compounds; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Databases, Genetic; Humans; Indoles; Prognosis; Protein Kinase Inhibitors; RGS Proteins; Signal Transduction; Urinary Bladder Neoplasms	2021

Article

Year

Genome-wide screening for the G-protein-coupled receptor (GPCR) pathway-related therapeutic gene

Bioengineered, 2021, Volume: 12, Issue:1

Bladder cancer is one of the most severe genitourinary cancers, causing high morbidity worldwide. However, the underlying molecular mechanism is not clear, and it is urgent to find target genes for treatment. G-protein-coupled receptors are currently a target of high interest for drug design. Thus, we aimed to identify a target gene-related to G-protein-coupled receptors for therapy. We used The Cancer Genome Atlas (TCGA) and DepMap databases to obtain the expression and clinical data of

Topics: Aza Compounds; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Databases, Genetic; Humans; Indoles; Prognosis; Protein Kinase Inhibitors; RGS Proteins; Signal Transduction; Urinary Bladder Neoplasms

2021